Burden of influenza-related hospitalizations among children with sickle cell disease
- PMID: 20100764
- PMCID: PMC3283164
- DOI: 10.1542/peds.2009-1465
Burden of influenza-related hospitalizations among children with sickle cell disease
Erratum in
- Pediatrics. 2011 May;127(5):1007-9
Abstract
Objective: Children with sickle cell disease (SCD) are considered to be at high risk for complications from influenza infection despite minimal published data that characterize the burden of influenza in this population. Our objectives were to (1) estimate the rate of influenza-related hospitalizations (IRHs) among children with SCD, (2) compare this rate with rates of children with cystic fibrosis (CF) and children with neither SCD nor CF, and (3) explore mechanisms that underlie these potentially preventable hospitalizations.
Methods: We analyzed hospitalizations from 4 states (California, Florida, Maryland, and New York) across 2 influenza seasons (2003-2004 and 2004-2005) from the Healthcare Cost and Utilization Project State Inpatient Databases. We included hospitalizations with a discharge diagnosis code for influenza in a child <18 years of age. We used census data and disease prevalence estimates to calculate denominators and compare rates of IRH among children with SCD, CF, and neither disease.
Results: There were 7896 pediatric IRHs during the 2 influenza seasons. Of these, 159 (2.0%) included a co-occurring diagnosis of SCD. Annual rates of IRHs were 112 and 2.0 per 10 000 children with and without SCD, respectively, across both seasons. Children with SCD were hospitalized with influenza at 56 times (95% confidence interval: 48-65) the rate of children without SCD. Children with SCD had approximately double the risk of IRH compared with children with CF (risk ratio: 2.1 [95% confidence interval: 1.5-2.9]). IRHs among children with SCD were not longer, more costly, or more severe than IRHs among children without SCD; they were also rarely nosocomial and co-occurred with a diagnosis of asthma in 14% of cases.
Conclusions: IRHs are substantially more common among children with SCD than among those without the disease, which supports the potential importance of vigorous influenza vaccination efforts that target children with SCD.
Conflict of interest statement
Similar articles
-
Influenza vaccination rates and hospitalizations among Medicaid enrollees with and without sickle cell disease, 2009-2015.Pediatr Blood Cancer. 2021 Dec;68(12):e29351. doi: 10.1002/pbc.29351. Epub 2021 Sep 20. Pediatr Blood Cancer. 2021. PMID: 34542932 Free PMC article.
-
Estimates of hospitalization attributable to influenza and RSV in the US during 1997-2009, by age and risk status.BMC Public Health. 2017 Mar 21;17(1):271. doi: 10.1186/s12889-017-4177-z. BMC Public Health. 2017. PMID: 28320361 Free PMC article.
-
Epidemiology and disease burden of sickle cell disease in France: A descriptive study based on a French nationwide claim database.PLoS One. 2021 Jul 9;16(7):e0253986. doi: 10.1371/journal.pone.0253986. eCollection 2021. PLoS One. 2021. PMID: 34242255 Free PMC article.
-
Global Role and Burden of Influenza in Pediatric Respiratory Hospitalizations, 1982-2012: A Systematic Analysis.PLoS Med. 2016 Mar 24;13(3):e1001977. doi: 10.1371/journal.pmed.1001977. eCollection 2016 Mar. PLoS Med. 2016. PMID: 27011229 Free PMC article. Review.
-
Pediatric influenza.Pediatr Nurs. 2009 Nov-Dec;35(6):335-45. Pediatr Nurs. 2009. PMID: 20166462 Review.
Cited by
-
SARS-CoV-2 with Influenza B Coinfection in a Patient with Sickle Cell HbSC Presenting with Painful Crisis: A Case Report.Cureus. 2024 Mar 13;16(3):e56102. doi: 10.7759/cureus.56102. eCollection 2024 Mar. Cureus. 2024. PMID: 38618320 Free PMC article.
-
Description of a national, multi-center registry of patients with sickle cell disease and SARS-CoV-2 infection: Data from the Pediatric COVID-19 United States Registry.Pediatr Blood Cancer. 2024 Jun;71(6):e30909. doi: 10.1002/pbc.30909. Epub 2024 Mar 12. Pediatr Blood Cancer. 2024. PMID: 38469996
-
Inflammatory status in pediatric sickle cell disease: Unravelling the role of immune cell subsets.Front Mol Biosci. 2023 Jan 10;9:1075686. doi: 10.3389/fmolb.2022.1075686. eCollection 2022. Front Mol Biosci. 2023. PMID: 36703915 Free PMC article.
-
Side effects following COVID-19 vaccination in pediatric patients with sickle cell disease.Pediatr Blood Cancer. 2023 Mar;70(3):e30193. doi: 10.1002/pbc.30193. Epub 2022 Dec 30. Pediatr Blood Cancer. 2023. PMID: 36583456 Free PMC article.
-
The Cause-Effect Dilemma of Hematologic Changes in COVID-19: One Year after the Start of the Pandemic.Hematol Rep. 2022 Mar 28;14(2):95-102. doi: 10.3390/hematolrep14020014. Hematol Rep. 2022. PMID: 35466178 Free PMC article. Review.
References
-
- Neuzil KM, Mellen BG, Wright PF, Mitchel EF, Jr, Griffin MR. The effect of influenza on hospitalizations, outpatient visits, and courses of antibiotics in children. N Engl J Med. 2000 Jan 27;342(4):225–231. - PubMed
-
- Ampofo K, Gesteland PH, Bender J, et al. Epidemiology, complications, and cost of hospitalization in children with laboratory-confirmed influenza infection. Pediatrics. 2006 Dec;118(6):2409–2417. - PubMed
-
- Thompson WW, Shay DK, Weintraub E, et al. Influenza-associated hospitalizations in the United States. JAMA. 2004 Sep 15;292(11):1333–1340. - PubMed
-
- O'Brien MA, Uyeki TM, Shay DK, et al. Incidence of outpatient visits and hospitalizations related to influenza in infants and young children. Pediatrics. 2004 Mar;113(3 Pt 1):585–593. - PubMed
-
- Jansen AG, Sanders EA, Hoes AW, van Loon AM, Hak E. Influenza- and respiratory syncytial virus-associated mortality and hospitalisations. Eur Respir J. 2007 Dec;30(6):1158–1166. - PubMed
Publication types
MeSH terms
Grants and funding
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical
